Why are drug trials in Alzheimer's disease failing?
Thursday, August 26, 2010 - 17:42
in Health & Medicine
An Editorial in this week's Lancet discusses the poor record of drug trials in Alzheimer's disease, following the dumping of semagacestat on the phase 3 scrapheap of other failed disease-modifying drugs for the condition.
